Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lannett Company, Inc.

https://www.lannett.com/

Latest From Lannett Company, Inc.

Cipla's Advair Generic US Debut May Be Pushed Out But 'Value Intact'

Cipla to pursue two-site, de-risked filing approach for large respiratory assets even as it awaits an FDA compliance classification for its Indore facility, which will determine the launch timelines for its much-awaited generic Advair in the US.

Commercial Sales & Earnings

Lannett Gears Up For Chapter 11 Bankruptcy, Lenders To Take Ownership

Lannett had cautioned that a major restructuring was likely as its operations and balance sheet faltered under a massive debt pile – now that has become a reality, under a proposed plan that will hand the company keys to lenders.

Deals Financing

Lannett Shares Banished From NYSE, Trading OTC

Lannett investors and creditors must brace for further bad news after the Philadelphia-based Rx and OTC drug firm was struck from the New York Stock Exchange.

OTC Drugs Regulation

Lannett Heads To The Pink Sheets As Financial Woes Continue

Lannett investors and creditors must brace for further bad news after the Philadelphia-based player was struck from the New York Stock Exchange.

Regulation Financing
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Other Names / Subsidiaries
    • Kremers Urban Pharmaceuticals, Cody Laboratories, Silarx Pharmaceuticals
UsernamePublicRestriction

Register